Administration, Intravenous

Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone treatment, results of an administrative claims analysis show.

DENVER — Treatment with IV efgartigimod improved functionality for individuals with acetylcholine receptor-positive generalized myasthenia gravis, according to a poster from the American Academy of Neurology annual meeting.

Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV administration of the medication, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.